AHB
FBIO icon

Abner Herrman & Brock’s Fortress Biotech FBIO Stock Holding History

Abner Herrman & Brock’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-6,920
Closed -$493K – 127
2017
Q2 		$493K Buy
+6,920
New +$409K 0.09% 89

Other funds holding FBIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return

Abner Herrman & Brock's FBIO Position: Q3 2017 in Review

Abner Herrman & Brock sold out of Fortress Biotech (FBIO) in Q3 2017, closing a stake of 6,920 shares — an estimated $493K sold.

Abner Herrman & Brock first reported a position in FBIO in Q2 2017 and held it in 1 quarter. The position peaked at $493K in Q2 2017. 58 funds tracked by Wall St. Rank hold FBIO as of Q3 2017.

  • Abner Herrman & Brock reported no remaining Fortress Biotech position as of Q3 2017 after selling out during the quarter.
  • Abner Herrman & Brock sold 6,920 Fortress Biotech shares in Q3 2017, an estimated $493K.
  • Abner Herrman & Brock first reported a position in Fortress Biotech in Q2 2017 and held it in 1 quarter.
  • Abner Herrman & Brock's Fortress Biotech position peaked at $493K in Q2 2017.
  • 58 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2017.

Based on Abner Herrman & Brock's 13F filing for Q3 2017, filed 6 Oct 2017.